Kelly Brooks

Kelly Brooks is currently a Global Study Associate Director at AstraZeneca, leading cross-functional study teams to ensure the successful delivery of clinical studies. Previously, Kelly served as a Global Study Manager at AstraZeneca, overseeing oncology studies and managing vendor relationships. Prior to that, Kelly worked at the University Health Network as a Clinical Study Coordinator, gaining substantial experience in oncology trials, data management, and regulatory training. Kelly holds a Bachelor of Science in Life Science from McMaster University and a Clinical Research certification from Humber College.